Fermenta wins 3 "excellence" categories at India Pharma Awards 2018
Fermenta Biotech Limited, a 91.2% subsidiary of DIL Limited, has received “Excellence in Corporate Social Responsibility”, “Excellence in Export Promotion” and “Pharma International Excellence” awards at India Pharma Awards 2018.
The awards were given during Pharma Week at CPHI India – South East Asia’s largest pharmaceutical event.
Commenting on the Award Mr. Prashant Nagre, CEO, Fermenta Biotech Limited said: “The awards are recognition of the efforts put in by the company to remain ahead of the curve in the
competitive global environment.
As a responsible citizen, it has always been our belief to give back to the community we are present in. The
award was for empowering local communities to create sustainable growth.
The excellence in export promotion award recognises our steady growth over the years and demonstration of
increasing our global footprint to across 50+ countries over six continents.
The Pharma International Excellence Award honored FBL for achieving success in international markets through
world class strategy and operations. From re-engineering business processes through implementation of SAP
and CRM initiative like salesforce.com to embracing best in class practices for value enhancement across
verticals, FBL is focused on a robust and sustainable future.
We are trusted partners for our customers and have consistently delivered on quality products with help of
our R&D and Internationally benchmarked manufacturing practices. This has helped us improve our
profitability over the years. The Export Promotion award along with the International Excellence award are a
testimony of our capabilities, product quality and a highly experienced team committed to consistent delivery.”
